Genetic engineering can already tweak individual biological traits in laboratory animals and, in a handful of cases, in human cells. Researchers have made mice with bigger muscles, denser bones, sharper memories, and longer lifespans by editing single genes. But assembling all of those upgrades into a living, breathing “superhuman” is a fundamentally different challenge, one that runs into the messy reality of how genes interact with each other, with the environment, and with trade-offs that evolution spent millions of years negotiating. The science is real and advancing fast, yet the gap between editing a gene in a mouse embryo and safely enhancing a healthy adult person remains enormous.
Single-Gene Traits Where the Science Is Furthest Along
The most convincing demonstrations of genetic enhancement involve traits controlled by one gene, or a small handful, where flipping a switch produces a dramatic physical change. These are the cases that feed superhuman fantasies, and they are worth understanding in detail because they show both what is possible and where the limits appear.
Muscle Mass and Strength
Myostatin is a protein that acts as a brake on muscle growth. Remove that brake, and muscle fibers multiply and enlarge. In mice, knocking out the myostatin gene with CRISPR produces animals with visibly bulkier muscles and improved differentiation of muscle stem cells.1PubMed Central. CRISPR/Cas9-Targeted Myostatin Deletion Improves the Myogenic Differentiation Parameters for Muscle-Derived Stem Cells in Mice A separate approach, delivering a gene that produces a myostatin-blocking protein in a single injection, boosted muscle mass and strength in both young and old mice for over two years.2PubMed Central. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors The effect is not confined to rodents. A large study of humans carrying naturally occurring loss-of-function variants in the myostatin gene found that carriers had more lean mass, greater grip strength, and less body fat, with some heterozygous carriers showing muscle mass increases above ten percent across multiple muscle groups.3PubMed Central. Humans with function-disrupting variants in the myostatin gene So the blueprint for genetically enhanced strength exists in real people already. Engineering it deliberately is a different matter.
Bone Density
A family identified in the early 2000s carried a mutation in the LRP5 gene that gave them unusually dense bones and elevated markers of bone formation, with no apparent downsides.4PubMed. High bone density due to a mutation in LDL-receptor-related protein 5 Since then, mice engineered to carry a similar gain-of-function LRP5 mutation have shown thicker cortical bone, denser trabecular architecture, and measurably stronger bones under mechanical testing.5PubMed. The high-bone-mass phenotype of novel transgenic mice with LRP5 A241T mutation Even dental implants integrate better into the bone of these transgenic mice.6PubMed. Lrp5 A241T High-Bone-Mass Mutation Enhances Implant Osseointegration The concept of fracture-resistant bone through gene editing is grounded in real biology, though nobody has attempted this in a living human.
Pain Insensitivity
The SCN9A gene encodes a sodium channel expressed heavily in pain-sensing neurons. People born with loss-of-function mutations in both copies of this gene feel no pain at all, a condition called channelopathy-associated insensitivity to pain.7PubMed Central. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations On the other end of the spectrum, activating mutations in the same gene cause severe pain disorders.8PubMed Central. Pain perception is altered by a nucleotide polymorphism in SCN9A This makes SCN9A an appealing target: you could theoretically tune pain sensitivity up or down. But complete pain insensitivity is actually dangerous. People who cannot feel pain accumulate injuries, infections, and joint damage because they lack the warning signal. “Enhanced” is not the same as “off,” and finding the right dial setting for a sodium channel in millions of neurons is far harder than flipping it to zero in a dish.
Natural Short Sleep
Most people need seven to nine hours of sleep. A small number of families carry a mutation in the DEC2 gene that lets them sleep around six hours or less without the cognitive fog, weakened immunity, or metabolic problems that normally accompany short sleep.9PubMed Central. A familial natural short sleep mutation in dec2 extends healthspan and lifespan in Drosophila In fruit flies engineered with the equivalent human mutation, the short-sleep phenotype was replicated and appeared to extend healthy lifespan.10PubMed Central. A familial natural short sleep mutation promotes healthy aging and extends lifespan in Drosophila An extra two waking hours per day with no health penalty sounds like a superpower, and it is one that already exists naturally in a tiny fraction of the population.
HIV Resistance
People homozygous for a 32-base-pair deletion in the CCR5 gene are almost completely resistant to HIV infection, regardless of how many times they are exposed. The mutation produces a nonfunctional version of the receptor that HIV uses to enter immune cells.11PubMed Central. Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation CRISPR has been explored as a way to introduce this deletion into patients’ cells.12PubMed. The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant This is the most famous single-gene enhancement example, and also the most famous cautionary tale: CCR5 deletion increases vulnerability to West Nile virus encephalitis.11PubMed Central. Legacy of a magic gene-CCR5-∆32: From discovery to clinical benefit in a generation The gene you are removing was doing something useful.
Memory and Intelligence in Lab Animals
Among the most striking enhancement experiments are those targeting cognition. In 1999, researchers created transgenic mice overexpressing the NR2B subunit of the NMDA receptor in their forebrains. These “Doogie mice” (named after the TV prodigy) showed superior learning and memory across a range of behavioral tasks.13PubMed. Genetic enhancement of learning and memory in mice The finding was later extended to rats, with NR2B overexpression again boosting memory and synaptic plasticity, suggesting the effect holds across mammalian species.14PLoS ONE. Genetic Enhancement of Memory and Long-Term Potentiation but Not CA1 Long-Term Depression in NR2B Transgenic Rats Other strategies for upregulating NR2B, including targeting its recycling pathway, have also improved memory performance in rodents.15PubMed. Targeting the NMDA receptor subunit NR2B for treating or preventing age-related memory decline
The leap from mouse memory to human intelligence is where optimism should cool sharply. Human intelligence is influenced by thousands of genetic variants, each contributing a tiny amount. Polygenic scores built from genome-wide studies can predict some educational and cognitive outcomes at a population level, but when tested within families, where siblings share the same household environment, those predictions drop by a third to a half.16Intelligence & Cognitive Abilities. Polygenic Score Prediction Within and Between Sibling Pairs for Intelligence, Cognitive Abilities, and Educational Traits From Childhood to Early Adulthood That shrinkage means a significant chunk of what looks like genetic influence on intelligence is actually tangled up with family environment, social sorting, and other non-genetic factors. You cannot CRISPR your way past those confounds. Boosting one receptor subunit in a mouse brain and making a human “smarter” are separated by a complexity gap that no current technology can bridge.
Aging and Lifespan Extension
In one landmark experiment, mice treated with a virus delivering the telomerase gene at one year of age (roughly equivalent to middle age in human terms) saw their median lifespan increase by about a quarter. Even mice treated at two years old, already elderly, gained a thirteen-percent lifespan boost. The treated animals also showed improvements in insulin sensitivity, bone density, neuromuscular coordination, and multiple molecular markers of aging, and the effect required active telomerase enzymatic activity to work.17PubMed Central. Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer The researchers saw no increase in cancer, a major concern because telomerase is normally active in tumor cells. Whether this safety profile would hold in humans, whose cells face decades more cumulative mutation risk, remains unknown.
Why You Cannot Just Stack All the Upgrades
Each of the examples above involves changing one gene in one system. A “superhuman” would presumably want all of them and more, simultaneously, in a single body. Several biological realities make this impractical today and possibly for a long time.
The CCR5 story illustrates the core problem of trade-offs: a gene that leaves you vulnerable to one pathogen may protect you against another. Evolutionary pressures have already optimized many of these systems, and the variants we carry represent compromises between competing demands. A recent preprint analyzing genetic trade-offs across large cohorts found evidence of fundamental tensions between fertility, longevity, and disease susceptibility, suggesting that boosting one trait genetically may come at the cost of another.18PubMed Central. Why do we get sick? Genetic evidence for evolutionary trade-offs between fertility, longevity, and disease
Beyond trade-offs, there is the problem of epigenetics. Your DNA sequence is only part of the story. Chemical marks on top of DNA, things like methylation patterns, alter which genes are active in which tissues and when. Environmental exposures, diet, stress, and infections all reshape these marks throughout life.19PubMed Central. Epigenetics: connecting environment and genotype to phenotype and disease You could edit a gene perfectly and still see a different outcome depending on the epigenetic context surrounding it. The genome is not a switchboard where each gene has one function and one consequence.
Getting the Edit Into the Right Cells
Even if you knew exactly which genes to change, you would need a way to deliver the editing machinery to the right tissues inside a living person. Lipid nanoparticles, the same basic technology used in mRNA vaccines, are the leading delivery vehicle for gene therapies.20PubMed Central. Lipid Nanoparticles: A Novel Gene Delivery Technique for Clinical Application The problem is that these particles tend to accumulate in the liver. Reaching other organs, like muscle, bone, or brain, requires significant new engineering.21PubMed. On the mechanism of tissue-selective gene delivery by lipid nanoparticles Recent progress has produced nanoparticles incorporating peptide-based ionizable lipids that can target the lungs, spleen, thymus, and bone in addition to the liver.22PubMed. Tissue-specific mRNA delivery and prime editing with peptide-ionizable lipid nanoparticles That is encouraging, but notice the brain is not yet on that list. Enhancing cognition or sleep patterns through gene delivery in a living adult would require crossing the blood-brain barrier, one of the toughest delivery challenges in all of medicine.
Off-Target Edits and Mosaicism
CRISPR does not always cut where you intend. Studies of gene editing in bovine embryos found mosaicism, where some cells carry the edit and others do not, in nearly all treated embryos regardless of whether the editing tool was delivered as mRNA or protein.23PubMed Central. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos Beyond mosaicism, unintended mutations at sites resembling the target sequence have been repeatedly documented, and the methods used to detect these events may not be sensitive enough to catch all of them.24PubMed Central. The technical risks of human gene editing For a therapeutic edit in a sick patient, some level of off-target risk may be acceptable. For an enhancement in a healthy person, the calculus is different: you are introducing risk with no disease to offset it. This asymmetry shapes how regulators and ethicists think about the superhuman question.
Psychological Resilience and the Limits of Gene-Based Enhancement
Discussions about superhumans tend to focus on physical traits, but what about emotional toughness, stress tolerance, or resilience? These are influenced by genetics too, but in the messiest possible way. Candidate gene research has identified at least eight genes associated with psychological resilience, including variants linked to serotonin transport, dopamine receptors, the stress hormone system, and the oxytocin receptor. The specific variants associated with resilience sometimes differ by context, with a given allele protective against depression in one study but neutral or harmful in another. Resilience is also deeply shaped by childhood experience, social support, and coping strategies, all factors no gene edit can provide. This is the trait-enhancement domain where genetics alone seems least likely to deliver meaningful results.
The Regulatory Reality
Most of these enhancements would need to be heritable to work fully, meaning they would have to be made in embryos or reproductive cells. A survey of 96 countries found that 75 prohibit heritable human genome editing for reproductive purposes, with 70 banning it outright and five allowing it only with exceptions.25PubMed Central. The impact of the three major human genome editing reports on the governance landscape None clearly permits it. Even somatic gene therapy, edits that affect only the treated person and are not passed to offspring, faces strict regulatory hurdles in most countries when applied to healthy individuals. The He Jiankui case in 2018, when a Chinese researcher edited CCR5 in human embryos and implanted them, was met with near-universal condemnation from the scientific community and a prison sentence for He himself. The regulatory environment makes state-sanctioned superhuman engineering effectively impossible in any country with functioning bioethics oversight.
The equity concern looms large even in hypothetical scenarios. If enhancement editing ever became available, access would initially be limited to the wealthy, raising the prospect of a genetic upper class with engineered advantages in health, cognition, and longevity.26ResearchGate. The Ethics of Genetic Enhancement: Examining the Societal Consequences of Unregulated Gene Editing for the Elite That scenario echoes older eugenic ideologies in uncomfortable ways, and it is one reason many bioethicists argue that even if the technology becomes safe, its use for enhancement should remain restricted.
Gene Doping in Sports
The nearest-term application of genetic enhancement for healthy people is probably not medicine but athletics. The World Anti-Doping Agency already lists gene doping as a prohibited method and has approved certain detection techniques.27PubMed. Gene Doping Detection From the Perspective of 3D Genome Current detection relies primarily on quantitative PCR, which can identify known transgene sequences in blood or urine. But these methods are vulnerable to workarounds, such as optimizing the codon sequence of a delivered gene so it looks less like an obvious synthetic construct.28PubMed. Gene doping detection in the era of genomics Researchers are exploring high-throughput DNA sequencing as a more comprehensive detection tool, and mouse models have shown that both direct and indirect proof of gene doping (through delivered DNA and altered RNA expression patterns) can be detected.29PubMed Central. Detection Method for Gene Doping in a Mouse Model Expressing Human Erythropoietin from Adeno-Associated Virus Vector-9 The cat-and-mouse dynamic between doping and detection is likely to intensify as gene delivery tools improve.
What makes gene doping particularly concerning is that the same myostatin-blocking or erythropoietin-boosting strategies demonstrated in animal models could theoretically be applied to an athlete. A single injection producing a lasting change in muscle mass or oxygen-carrying capacity would leave no daily chemical residue of the kind traditional drug tests look for. Anti-doping agencies are aware of this trajectory, which is why detection research is moving toward genomic approaches that look at the full picture rather than screening for one substance at a time.
Expanding the Genetic Alphabet
Beyond editing existing human genes, some researchers are exploring whether the genetic code itself can be expanded. Standard biology uses four DNA bases and twenty amino acids. Synthetic biology techniques called genetic code expansion allow engineered organisms to incorporate nonstandard amino acids into proteins, creating molecules with properties that natural biology never produces.30Chemical Reviews. Genetic Code Expansion: Recent Developments and Emerging Applications This work is currently limited to bacteria and cell cultures, and it is aimed more at producing novel drugs and materials than at upgrading humans. But it represents a longer-horizon version of the superhuman question: not just editing the genes we have, but giving biology tools it never evolved on its own. Whether any version of this technology could safely operate inside a living human body is a question nobody can currently answer, and it may be decades before it is even worth asking seriously.